Sanofi And PAGB Call On UK MHRA To Explore Exclusivity For First-In-Class Rx-To-OTC Switches
Executive Summary
Exclusivity for first-in-class Rx-to-OTC switches should be on the table as part of a wider review of the UK’s reclassification process, say Sanofi and PAGB.